Top Stories

The GP’s background in aerospace and defense is attracting more European LPs.

Butterfly Equity, CapMan, Clearstone and Fondaction are among the PE firms transacting in the better-for-you nutrition sector.

Buyers and sellers are increasingly aligned for assets in the real economy with predictable cashflows are finding, Stévenin told PE Hub.

'Momentum is driven by the declining cost of capital and strong operating fundamentals,' the Blackstone executive told PE Hub.

'Banks are pitching a lot more exits, and there’s more being lined up for 2026. People are more confident that if you’ve got a decent asset, you’re going to have a successful process rather than everything breaking.'

Managing director discusses how Trivest tackled business services dealmaking in 2025 and why he remains bullish about 2026.

'Many investors still view sustainability as complementary rather than a fundamental driver of growth.'

Ardian, CapVest, Frazier Healthcare Partners and Nautics are among the PE firms investing in specialty pharmacy and pharmaceutical assets.

'Many sponsors hold large, mature portfolios and there is an increasing need to return capital as fund lives stretch. With cleaner run‑rates and more predictable trading, more assets will come to market.'

'No one knows this business better than its founder and CEO,' said One Equity's Inna Etinberg about InfuCare's Deven Patel.